In clinical practice, tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19–9 are often used for the detection of adenocarcinomas [3,5,6]. The gene discussed is CEACAM5; the disease is adenocarcinoma.